the high CVD risk smoker

Similar documents
Secondary prevention and systems approaches: Lessons from EUROASPIRE and EUROACTION

Models of preventive care in clinical practice to achieve 25 by 25

EUROPEAN SURVEY OF CARDIOVASCULAR DISEASE PREVENTION AND DIABETES EUROASPIRE IV. GUY DE BACKER Ghent University,Belgium

Smokefree Policies in Europe: Are we there yet?

Prevention in Europe

EUROACTION A model for secondary and primary preventive care to achieve 25 by 25

DECLARATION OF CONFLICT OF INTEREST. None

Overview of drug-induced deaths in Europe - What does the data tell us?

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Cross Border Genetic Testing for Rare Diseases

The Quit Clinic As an Anti-smoking Advocacy Tool

Alcohol in Europe and Brief Intervention. Dr Lars Møller Programme Manager World Health Organization Regional Office for Europe

European Collaboration on Dementia. Luxembourg, 13 December 2006

Underage drinking in Europe

European status report on alcohol and health Leadership, awareness and commitment

The Economics of Tobacco Control and Tobacco Taxation: Challenges & Opportunities for a Tobacco Free Turkey

PRESS RELEASE ISSUED BY THE STATE UNIVERSITY OF NEW YORK AT ALBANY

Post-test of the advertising campaign Help

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SWEDEN

SPECIAL EUROBAROMETER 332. Fieldwork: October 2009 Publication: May 2010

WCPT COUNTRY PROFILE December 2017 SERBIA

Prevention of Oral Cancer Special Interest Working Group

EUROACTION. A European Society of Cardiology Demonstration Project in Preventive Cardiology FINAL RESULTS

Engagement in language assessment / Regions of Europe

European Association of Dental Public Health Prevention of Oral Cancer

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

Alcohol-related harm in Europe and the WHO policy response

Registration and management of smoking behaviour in patients with coronary heart disease

UK bowel cancer care outcomes: A comparison with Europe

Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration

The health economic landscape of cancer in Europe

THE CVD CHALLENGE IN NORTHERN IRELAND. Together we can save lives and reduce NHS pressures

Guidelines on cardiovascular risk assessment and management

Table 7.1 Summary information for lung cancer in Ireland,

Smoking Cessation Interventions In Hospital Settings: Implementing the Evidence

Smoking Cessation: Good News at Last!

Project Meeting Prague

Atherosclerotic Cardiovascular Diseases: ischaemic heart disease and stroke

2008 EUROBAROMETER SURVEY ON TOBACCO

The EUROASPIRE surveys: lessons learned in cardiovascular disease prevention

A new scale to measure tobacco control activity in a country: data tables and questionnaire

Primary and secondary prevention of sudden cardiac death in emerging economies

Palliative nursing care of children and young people across Europe

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

LEBANON. WCPT COUNTRY PROFILE December 2018

Perspectives for information on alcohol use in the EU

Table 6.1 Summary information for colorectal cancer in Ireland,

DENMARK. WCPT COUNTRY PROFILE December 2018

European Status report on Alcohol and Health

Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries

Monthly measles and rubella monitoring report

Declaration of Conflict of Interest. No potential conflict of interest to disclose with regard to the topics of this presentations.

GERMANY. WCPT COUNTRY PROFILE December 2018

Rheumatoid Arthritis Disease Burden and Access to Treatment

TWIN VALLEY BEHAVIORAL HEALTHCARE CLINICAL GUIDELINES FOR MANAGEMENT OF SMOKING CESSATION

Alcohol Prevention Day

Saudi Arabia February Pr Michel KOMAJDA. Université Pierre et Marie Curie Hospital Pitié Salpétrière

Table 9.1 Summary information for stomach cancer in Ireland,

Where we stand in EFORT

Overview of European Consumption Databases

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

The Risk of Alcohol in Europe. Bridging the Gap June 2004

European Community Pharmacy: a reference in Public Health

Q1 What age are you?

Development of Palliative Care services in different countries

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

National Institute on Alcohol Abuse and Alcoholism. Environmental Approaches

Critical immunity thresholds for measles elimination

Brief Intervention for Smoking Cessation. National Training Programme

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

Risk perception and food safety: where do European consumers stand today?

EFSA s activities on data collection (Art. 33) and proposal for a new initiative (EUMENU) H. Deluyker Director

EConDA Economics of Chronic Diseases

Grown-up congenital heart disease care throughout Europe

Europa Donna in Europe and in Slovenia

Screening for Cervical Cancer in Europe

EUROBAROMETER SPECIAL 332. Fieldwork: October 2009 Publication: May 2010

Men & Health Work. Difference can make a difference Steve Boorman & Ian Banks RSPH Academy 2013

Building a european consensus on minimum quality standards for drug treatment, rehabilitation and harm reduction

Smoking Counselling and Cessation Service in Hospital Authority 7 May HA Convention 2014

Cardiovascular Disease and Diabetes Policies for Better Health and Quality of Care

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd ( Page 1 5/18/2015

A report on the epidemiology of selected vaccine-preventable diseases in the European Region 30% 20% 10%

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Standards of Care in Epilepsy Current Access to Basic Epilepsy Care Across the European Union

Outcome of proficiency test on EIA serology

EUROPEAN CITIZENS DIGITAL HEALTH LITERACY

Prof. Renata Cífková, MD, CSc.

The cancer burden in the European Union and the European Region: the current situation and a way forward

UMASS TOBACCO TREATMENT SPECIALIST CORE TRAINING

Young people and drugs. Analytical report

Transcription:

Smoking Cessation: population and patients A comprehensive approach to the smoker the high CVD risk smoker Catriona Jennings Cardiovascular Specialist Research Nurse Imperial College London European Society of Cardiology, Stockholm, Sweden August 28 th to September 1 st 2010

WHO Strategy for Tobacco Control Populations Provide a supportive environment, e.g higher taxation, price, smoking bans in public places and mass media and educational campaigns Individual smokers Initiate policies and activities to help dependent smokers who are motivated to quit smoking WHO Europe 2000

What are we doing as health professionals?

EUROASPIRE III Netherlands Finland Ireland Russia UK Latvia Germany Lithuania Czech Republic Poland France Belgium Romania Hungary Croatia Slovenia Greece Bulgaria Spain Italy Cyprus Turkey ESC - EUROASPIRE III - EHS

Prevalence of smoking in patients at interview by age and sex Coronary patients 17% (men 19%/ women 11%) Kotseva et al. 2009 Eur J Cardiov Prev R; 16: 121-37. Kotseva et al. 2010 Eur J Cardiov Prev R; High risk individuals 17% (men 23%/ women 13%) All Men Women

Persistent smoking Kotseva et al. 2009 Eur J Cardiov Prev R; 16: 121-37. Coronary patients who were smokers at the time of their diagnosis Kotseva et al. 2010 Eur J Cardiov Prev R; High risk individuals who were smokers when recruiting treatment started

Challenges for smoking cessation in this population Multiple issues to address eg. smoking, overweight, blood pressure, lipids A high proportion may not say they want to quit initially Heavily dependent on tobacco (age, years smoking) Several past quit attempts may lack confidence to succeed Weight gain additional risks Risk of relapse

Who is most likely to quit? (EUROASPIRE II Scholte et al 2005) Older patients > 60 years (OR 1.6) Patients with a higher level of education (OR 1.8) Post MI (OR 1.3) Under cardiologist (OR 1.4)

Who is less likely to quit? Challenge is very different for patients who have had an acute cardiac event compared to those who have not: E.g. Have a high total risk score

Success in smoking cessation with coronary patients

EUROACTION Cluster randomised controlled trial in 8 countries 24 centres 10,000+ subjects

Impact of a first cardiac event on smoking behaviour (EUROACTION) Smoking in month prior to event 35% Smoking at initial assessment (median 21 days post event) 10% Challenge was relapse prevention

EUROACTION: coronary patients Smoking cessation at one year in coronary patients who were smokers in the month prior to their event + 10% ( - 0.3% to + 21%) p = 0.06 Wood et al 2008 Lancet 371: 1999 2012

EUROACTION: coronary patients still smoking at one year Nearly three quarters had attempted to quit 1% reported using NRT to help with a quit attempt A half reported having reduced cigarette consumption Reducing cigarette consumption without concomitant use of NRT leads to compensatory behaviour like deeper inhaling and holding for longer

MULTIFIT : home based cardiac rehabilitation RCT Stanford Group USA Nurse led case management post myocardial infarction Risk factor modification (smoking cessation, exercise training, diet-drug lipid modification) Smokers defined as smoking in 6 months prior to AMI (43%) Counselling at time of admission to hospital and up to six months of structured regular follow up mostly by telephone or mail One year results De Busk R, Miller N et al 1994

MULTIFIT results smoking cessation Use of NRT 10% Intervention 2% Usual Care All hospitalised patients with acute myocardial infarction 894 Eligible 709 Randomised 585 293 INT 292 UC Smoking at baseline 131 (45%) 121 (41%) Quit at 6 months 90 (69%) 66 (55%) Quit at 1 year 92 (70%) 64 (53%) p=0.03

Success in individuals at high CVD risk

EUROACTION: high risk individuals General Practice Non-smoking at one year in high risk patients + 0.8% (- 13% to + 15%) p = 0.9 Wood et al 2008 Lancet 371: 1999 2012

How effective can we be in helping people at high risk of developing CVD to quit smoking? INT UC Advised to quit 95% 51% Attempted to quit Used NRT to quit 53% 31% 13% 24% Clinic 20% 2% Used reduction 58% 57% Want to stop 56% 42% Smokers at one year EUROACTION GP

Is it worth trying to motivate smokers to quit if they are not planning to quit immediately? Inter99 Denmark Randomised population based intervention study (3 groups: intensive A, less intensive B, background C) Prevention of CVD and diabetes with nonpharmacological intervention addressing smoking, diet and physical activity Individual cardiovascular risk assessment with PRECARD and lifestyle consultation 2408 smokers in all (2168 in Group A offered group based smoking cessation)

Inter99 smoking cessation results for Group A Agreed to attend smoking cessation group n Quit Rate * % No serious plans to quit prior to lifestyle consultation % 575 35 84 Agreeing to quit in a group increased the likelihood of abstinence at 1 year OR 4.6 Majority would not have accessed traditional programmes eg UK NHS stop smoking *Continuously abstinent at end of group cessation programme Pisinger et al 2005 Prev Med 40 278 284

Predictors of success and failure Inter99 Higher socio-economic status Educational level in the unemployed made no difference Older age at onset of daily smoking Higher wish to quit at baseline Being male Having a job High nicotine dependence and smoking spouse predicted failure Pisinger et al 2005 Prev Med 40 285-292

Proposed model of smoking cessation for high CVD risk smokers Use motivational techniques to explore ambivalence and recruit apparently unmotivated smokers to attempt to quit How you ask Don t nag Raise sense of urgency Offer help Inform about effective treatments Get commitment

Motivational techniques How do you feel about your smoking? Reflecting back So what you are saying is that you can never see yourself giving up smoking? I can see that you have had no success with using nicotine patches, do you know about any other treatments? OR Can you tell me more about how you used the patches?

Proposed model of smoking cessation for high CVD risk smokers Assess dependence Fagerstrom Test for Nicotine Dependence Inform about effective treatments and withdrawal oriented therapy

Proposed model of smoking cessation for high CVD risk smokers Integrated lifestyle management Smoking cessation Tailored dietary advice following a detailed assessment Tailored physical activity and exercise advice following a detailed assessment Weight maintenance and minimisation of weight gain in overweight and obese quitters

Proposed model of smoking cessation for high CVD risk smokers Management of CVD risk factors Monitor blood pressure and observe for rise in longer term Monitor lipids expect rise in HDL-C Check for dysglycaemia in longer term

Proposed model of smoking cessation for high CVD risk smokers Relapse prevention Withdrawal oriented approach Structured and regular follow up Involve the partner and other family members (especially if they smoke)

Smokers at high total risk Not just smokers a number of risk factors and adverse lifestyles to address Need a total risk management approach

Family focussed nurse-led multidisciplinary case management approach for high CVD risk smokers in community Comprehensive initial assessment of lifestyle and risk factors aimed at smokers in all stages of motivation to quit by a nurse, dietitian and physical activity specialist Goal setting One to one Follow up with progress in achieving goals Multidisciplinary team meets with dedicated physician Weekly Group activities Group health promotion workshops Supervised exercise programme

www.myaction.org.uk Integrated nurse led multidisciplinary family focussed vascular prevention programme developed for the UK NHS 10 programmes in the UK and Ireland

EUROACTION + Intensive Smoking Cessation with Varenicline RCT in 4 countries UK Italy Netherlands Spain

Summary of key points In Europe smoking cessation support for vascular and high risk patients is inadequate We face numerous challenges in helping patients to quit Population at risk but without vascular disease present a particularly big challenge It is worth using motivational techniques and counselling patients to quit even if they do not present with a request for help Smokers with a high total CVD risk require a total management approach addressing both lifestyle and risk factors